ArellanoRodrig0 Profile Banner
Eduardo Arellano-Rodrigo, MD Profile
Eduardo Arellano-Rodrigo, MD

@ArellanoRodrig0

Followers
54
Following
122
Media
3
Statuses
114

Hematólogo de pura cepa. Hospital Clínic de Barcelona Inside @hospitalclinic @hematoclinicbcn #Thrombosis #Anticoagulation #MPN #MPNsm #GEMFIN

Barcelona, España
Joined August 2018
Don't wanna be here? Send us removal request.
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
3 months
RT @jvalentingg: 📢 ¡Ya disponible la edición 2025 del Manual de Recomendaciones GEMFIN en Neoplasias Mieloproliferativas Crónicas Filadelfi….
0
35
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
3 months
RT @jvalentingg: 🔴 Comienza nuestra IX Reunión Anual del grupo GEMFIN. Excelente programa educacional y revisión de proyectos en marcha. ¡M….
0
4
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
3 months
RT @jvalentingg: Outstanding talk by Dr. William Vainchenker at the GEMFIN Annual Meeting:.“Twenty years since the discovery of JAK2 V617F.….
0
3
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
3 months
RT @jvalentingg: ¡Recién salidas del horno! 📘 Presentamos en nuestra reunión anual las nuevas guías GEMFIN. Esperamos que sean una herramie….
0
7
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
3 months
RT @Wang_Yu_Hung: Defective #neutrophil clearance in #JAK2V617F myeloproliferative neoplasms drives #myelofibrosis via immune checkpoint #C….
0
5
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
3 months
RT @GonzaloHEM: It's out!! I am thrill to share with you our new paper in @BloodJournal where we show that JAK2 46/1 haplotype regulates PD….
0
7
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
4 months
RT @jvalentingg: Our latest study from the GEMFIN group has just been published in Blood Cancer Journal!.We report real-world data on the e….
Tweet card summary image
nature.com
Blood Cancer Journal - Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study
0
7
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
5 months
RT @jvalentingg: 📢Nos complace compartir que nuestros compañeros, @GonzaloHEM y JC Hernández-Boluda, han publicado dos artículos originales….
0
11
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
6 months
RT @gabrielaene10: Very happy to be part of this international collaboration 🇨🇦🇫🇷🇪🇸🇳🇿🇩🇪 defining the VITT-like Monoclonal Gammopathy of Thr….
Tweet card summary image
nejm.org
Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is associated with antibodies that target platelet factor 4 (PF4) and are heparin-independent. VITT antibodies are implicated in acute,...
0
4
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
7 months
RT @mercedesmontoro: 📢 La EPACAR-T evalúa mediante escalas validadas e identifica a los candidatos que pueden beneficiarse de soporte psico….
0
9
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
7 months
0
1
1
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
7 months
Circulating factors in JAK2V617F-mutated #MPN with splanchnic vein thrombosis induce endothelial proinflammatory and prothrombotic phenotypes, which are modulated by therapy.@blanca_demoner @martagarrote @BloodyMeri_Xell @jcgarciapagan @diaz_ricart .@hematoclinicbcn
Tweet media one
1
8
17
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
11 months
High-risk patients achieving complete hematological response to first-line hydroxyurea showed a reduced risk of arterial thrombosis, a lower rate of progression to myelofibrosis and better survival: Data from Spanish Registry of ET. #MPN @LeukemiaJnl .
nature.com
Leukemia - Prognostic value of response to first-line hydroxyurea according to IPSET stratification in essential thrombocythemia
0
3
6
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
11 months
Impact of Non-Driver Mutations on Thrombosis and Predictive Value of Arterial Thrombosis Score (ARTS) and Venous Thrombosis Score (VETS) in #myelofibrosis: Insights from the #GEMFIN Registry. #MPN #MPNsm @hematoclinicbcn @LeukemiaJnl .
Tweet card summary image
nature.com
Leukemia - Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
0
5
14
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
1 year
RT @EMERGENCIAS_NET: Emergencias con factor de impacto JCR 2023 de 5,4:.4ª de 54 revistas de urgencias.¡¡¡¡¡Primer decil!!!!.¡¡Primer cuart….
0
50
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
1 year
RT @mmonrealriete: The prognostic value of blood cellular indices in acute PE. Another #RIETEregistry manuscript
Tweet media one
0
9
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
1 year
RT @sehh_es: #NotaDePrensaSEHH | Un único #registro español englobará a todos los #pacientes con neoplasias mieloproliferativas para avanza….
0
1
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
1 year
RT @NEJM: Original Article: Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage (ANNEXA-I) .
0
41
0
@ArellanoRodrig0
Eduardo Arellano-Rodrigo, MD
1 year
RT @NEJM: The factor Xa inhibitor reversal agent andexanet reduced expansion of intracerebral hemorrhages caused by factor Xa inhibitors bu….
0
128
0